Chargement en cours...
Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients
BACKGROUND: Tolvaptan, an antagonist of the vasopressin V2 receptor is a novel oral diuretic that promotes water excretion selectively. We have used furosemide as a primary diuretic and added human atrial natriuretic peptide (hANP) if necessary for fluid management postoperatively in living-donor li...
Enregistré dans:
| Publié dans: | Ann Transplant |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
International Scientific Literature, Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6248066/ https://ncbi.nlm.nih.gov/pubmed/29311539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.905817 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|